New oral anticoagulants have been developed over the past several years. These include the factor Xa inhibitors and direct thrombin inhibitors. These anticoagulants have been tested for safety and efficacy against standard therapies including subcutaneous enoxaparin or oral warfarin. The following is a review of pertinent trials comparing the new oral anticoagulants to standard therapy.
|Number of pages||8|
|Journal||Osteopathic Family Physician|
|State||Published - 1 May 2015|
- Atrial fibrillation
- Deep vein thrombosis
- Pulmonary embolus